US equities
|
MU
$1,029.00
▲+0.00%
SNDK
$1,581.82
▲+0.00%
NVDA
$229.28
▲+0.00%
INTC
$104.70
▲+0.00%
SPCX
$162.57
▲+0.00%
META
$718.67
▲+0.00%
TSLA
$382.70
▲+0.00%
IREN
$35.19
▲+0.00%
MU
$1,029.00
▲+0.00%
SNDK
$1,581.82
▲+0.00%
NVDA
$229.28
▲+0.00%
INTC
$104.70
▲+0.00%
SPCX
$162.57
▲+0.00%
META
$718.67
▲+0.00%
TSLA
$382.70
▲+0.00%
IREN
$35.19
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Armata Pharmaceuticals, Inc. Common Stock
(NY:
ARMP
)
3.630
UNCHANGED
Delayed Quote
Updated: 8:00 PM EDT, Oct 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Armata Pharmaceuticals, Inc. Common Stock
Could the Next Breakthrough in Antibiotic Resistance Come From Viruses That Kill Bacteria?
October 28, 2025
Via
AB Newswire
Topics
Death
This $13M Biotech Has $40M in Pentagon Funding – Here’s Why BiomX Could Be Biotech’s Best-Kept Secret
June 26, 2025
This $13M Biotech Has $40M in Pentagon Funding – Here’s Why BiomX Could Be Biotech’s Best-Kept Secret
Via
News Direct
Armata Pharmaceuticals Inc. (NYSE:ARMP) Investor Alert: Investigation over Potential Wrongdoing
↗
May 20, 2021
San Diego, CA -- (SBWIRE) -- 05/20/2021 -- An investigation on behalf of investors in shares of Armata Pharmaceuticals Inc. (NYSE:ARMP) was announced over potential breaches of fiduciary duties by...
Via
SBWire
